» Articles » PMID: 38104037

A Novel Comprehensive Therapeutic Approach to the Challenges of Chronic Wounds: A Brief Review and Clinical Experience Report

Overview
Journal Adv Ther
Date 2023 Dec 16
PMID 38104037
Authors
Affiliations
Soon will be listed here.
Abstract

Following the clinical perspective and concept that a healthy body will not develop chronic wounds, the central approach for the treatment described here is based on an understanding of how the body transforms the wound microenvironment from a non-healing to a healing state. As part of a comprehensive treatment regimen that includes OCM™ (complete matrix), wound preparation, and skin protectant formulations, the OCM contains components for complete wound healing by attending to the individual needs required to promote the closure of each unique chronic wound. During application of the comprehensive treatment regimen in independent investigator-led trials, the total wound percentage average reduction over the first 4 weeks of treatment was 60% across multiple wound types; median time to total wound closure was 6.9 weeks. Safety testing of the OCM formulation shows no potential allergenicity, no potential sensitization, and no known product-related adverse events. Clinical trials evaluating the OCM formulation as part of the comprehensive treatment regimen of multiple wound types are underway. Results of clinical trials and real-world experiences will expand current knowledge of the wound-healing potential of this novel product.

Citing Articles

Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective.

Razavi Z, Aliniay Sharafshadehi S, Yousefi M, Javaheri F, Rahimi Barghani M, Afkhami H Arch Dermatol Res. 2025; 317(1):320.

PMID: 39888392 DOI: 10.1007/s00403-024-03790-8.


Antimicrobial effects of a multimodal wound matrix against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in an in vitro and an in vivo porcine wound model.

Gil J, Solis M, Strong R, Cassagnol R, Jozic I, Davis S Int Wound J. 2024; 21(10):e70059.

PMID: 39359044 PMC: 11447198. DOI: 10.1111/iwj.70059.


Network Pharmacology Study on Herb Pair in the Treatment of Chronic Skin Ulcers.

Wang Y, Ding T, Jiang X Curr Pharm Des. 2024; 30(17):1354-1376.

PMID: 38571354 DOI: 10.2174/0113816128288490240322055201.

References
1.
Eriksson E, Liu P, Schultz G, Martins-Green M, Rica Tanaka , Weir D . Chronic wounds: Treatment consensus. Wound Repair Regen. 2022; 30(2):156-171. PMC: 9305950. DOI: 10.1111/wrr.12994. View

2.
Iqbal A, Jan A, Wajid M, Tariq S . Management of Chronic Non-healing Wounds by Hirudotherapy. World J Plast Surg. 2017; 6(1):9-17. PMC: 5339604. View

3.
Edmonds M, Manu C, Vas P . The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021; 17:88-93. PMC: 7919962. DOI: 10.1016/j.jcot.2021.01.017. View

4.
McDaniel H, Marston W, Farber M, Mendes R, Owens L, Young M . Recurrence of chronic venous ulcers on the basis of clinical, etiologic, anatomic, and pathophysiologic criteria and air plethysmography. J Vasc Surg. 2002; 35(4):723-8. DOI: 10.1067/mva.2002.121128. View

5.
Abbade L, Lastoria S . Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005; 44(6):449-56. DOI: 10.1111/j.1365-4632.2004.02456.x. View